|
Patient data. |
||||
| Code |
Sex |
Age (y) |
post mortem interval (h) |
Parkinson +/- |
|
|
||||
| MH2 |
f |
94 |
43 |
- |
| MH3 |
f |
89 |
32 |
- |
| MH4 |
m |
66 |
24 |
- |
| MH6 |
m |
64 |
30 |
- |
| MH7 |
m |
74 |
22 |
- |
| mean ± SD. |
77.4 ± 13.52 |
30.2 ± 8.26 |
||
| MH5 |
f |
92 |
24 |
+ |
| MH8 |
m |
81 |
22 |
+ |
| MH9 |
m |
91 |
62 |
+ |
| MH10 |
m |
73 |
46 |
+ |
| MH11 |
f |
84 |
24 |
+ |
| mean ± SD. |
84.2 ± 7.79 |
35.6 ± 17.74 |
||
| Fisher Test p-value |
0.48 |
0.4 |
0.4 |
|
| across groups |
(n.s.) |
(n.s.) |
(n.s.) |
|
|
Patient data of both PD positive and negative samples. f = female; m = male; SD = standard deviation; Fisher Test p-value = p-value according to Fishers Exact Test (values smaller than 0.05 are considered significant), n.s. = not significant. | ||||
Werner et al. Proteome Science 2008 6:8 doi:10.1186/1477-5956-6-8 |
||||